Coverage Initiative for GLP-1 Medications in Medicare
CMS initiates a temporary coverage program for GLP-1 medications aiming to assist Medicare beneficiaries before full BALANCE Model implementation. Learn more.
Medicare Part D Coverage Tightens as GLP-1 Drug Costs and Prior Authorizations Rise
Medicare Part D sees near-universal prior authorization and rising out-of-pocket costs for GLP-1 drugs in 2025, reflecting insurer adjustments to new cost and regulatory pressures.